Package Leaflet: Information for the User
Alendronic Acid Weekly STADA 70 mg Tablets EFG
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What Alendronic Acid Weekly STADA is and what it is used for
2. What you need to know before you start taking Alendronic Acid Weekly STADA
3. How to take Alendronic Acid Weekly STADA
4. Possible side effects
5. Storage of Alendronic Acid Weekly STADA
6. Contents of the pack and additional information
Alendronatebelongs to a group of medicines called bisphosphonates. Alendronate stops bone loss and reduces the risk of vertebral and hip fractures.
Alendronic Acid Weekly STADA is used:
Alendronic Acid Weekly STADA is a weekly treatment.
Osteoporosis is a thinning and weakening of the bones. Initially, osteoporosis usually does not have symptoms, however, if left untreated, it can result in bone fractures. Although these are usually painful, vertebral fractures can go unnoticed until a loss of height occurs. Fractures can occur during daily activities, such as standing up, or from minor injuries that would not damage a normal bone. Fractures typically occur in the hip, spine, or wrist and can cause not only pain but also significant problems such as a hunched posture (“widow's hump”) and loss of mobility.
As well as treatment with Alendronic Acid Weekly STADA, your doctor may suggest changes to your lifestyle (e.g., exercise and dietary recommendations, quitting smoking) to help manage your condition. Consult with your doctor for more information on lifestyle changes.
Do not take Alendronate Sodium STADA Weeklyif you
If you think any of these cases apply to you, do not take the tablets. Consult your doctor and follow their advice. (See also section 3 “How to take Alendronate Sodium STADA Weekly”)
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Alendronate Sodium STADA:
You may be advised to have a dental check-up before starting treatment with Alendronate Sodium STADA.
It is essential to maintain good oral hygiene while taking Alendronate Sodium STADA. You should have regular dental check-ups during your treatment and contact your doctor or dentist if you experience any problems in your mouth or teeth, such as tooth loss, pain, or inflammation.
If you arebeing treated by a dentistor if you are planning to undergodental surgery or tooth extraction, inform your dentist that you are taking Alendronate Sodium STADA.
There may be irritation, inflammation, or ulceration of theesophaguswith symptoms of chest pain, burning, difficulty, or pain swallowing, especially if you do not follow the correct dosing instructions or your doctor's instructions (see also section 3 "How to take Alendronate Sodium STADA"). If you experience any of these symptomsstop takingAlendronate Sodium STADA andconsult your doctor immediately. See also section 4 "Possible side effects". If you ignore these symptoms and continue taking the tablets, it is likely that these throat reactions will worsen.
This medication may affect your blood calcium and phosphate levels. It is essential to inform your doctor that you are taking Alendronate Sodium STADA if you need to undergo ablood test.
Children and Adolescents
Alendronate Sodium STADA should not be administered to children or adolescents.
Other Medications and Alendronate Sodium STADA
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor if you are takingcorticosteroids(medications used to treat inflammation). You may need to undergo some tests before starting treatment with Alendronate Sodium STADA (e.g., dental examination).
You may experience stomach irritation if you take analgesics (e.g., aspirin, ibuprofen) with Alendronate Sodium STADA.
The following medications may interfere with the absorption of Alendronate Sodium STADA if taken at the same time:
Therefore, you should waitat least 30 minutesafter taking Alendronate Sodium STADA before taking any other medication (see also section 3 "How to take Alendronate Sodium STADA").
Taking Alendronate Sodium STADA with Food and Beverages
It is likely that foods and beverages (including mineral water) will make Alendronate Sodium STADA less effective if taken at the same time. Therefore, it is essential to follow the advice given in section 3. "How to take Alendronate Sodium STADA".
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
You should not take Alendronate Sodium STADA if you are or think you may be pregnant.
Breastfeeding
You should not take Alendronate Sodium STADA if you are breastfeeding.
Driving and Operating Machinery
Alendronate Sodium STADA may cause side effects (including blurred vision, dizziness, and severe bone, muscle, or joint pain) that may affect your ability to drive or operate machinery. Individual responses to Alendronate Sodium STADA may vary (see section 4 "Possible side effects").
Alendronate Sodium STADA contains lactose
If your doctor has told you that you have a lactose intolerance, consult with them before taking this medication.
Alendronate Sodium STADA contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet: that is, it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose of Alendronate Sodium STADA isone tabletonce a week(always choose the same day of the week).
It is very important that you carefully follow the instructions below to get the maximum benefit from your medication and avoid problems in your esophagus.
If you take more Alendronate Sodium STADA than you should
If you accidentally take too many tablets, drink a full glass of milk to prevent the tablets from taking effect and consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. Do not induce vomiting and do not lie down.
The symptoms of an overdose of alendronate may include
If you forget to take Alendronate Sodium STADA
If you forget to take a dose, take a single tablet the next morning after remembering. Do not take a double dose to compensate for the missed doses. Do not take two tablets on the same day. After that, take a tablet once a week, on the original day chosen. If unsure, consult your doctor.
If you interrupt treatment with Alendronate Sodium STADA
Always consult your doctor, if you want to stop taking Alendronate Sodium STADA or if you want to change the prescribed dosing schedule. Do not interrupt or suspend treatment without consulting your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop takingAlendronate Sodium STADA andconsult your doctor immediatelyif you have any of the following symptoms:
Other side effects include
Very common: (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people)
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above25ºC. Store in the original packaging to protect it from moisture.
Medications should not be disposed of through drains or in the trash. Deposit the packaging and medications you no longer need at the SIGRE point of your pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Alendronic Acid Weekly STADA
The active ingredient is alendronate sodium trihydrate. Each tablet contains 70 mg of alendronic acid as alendronate sodium trihydrate.
The other components are: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, and magnesium stearate.
Appearance of the product and contents of the package
Alendronic Acid Weekly STADA tablets are presented in oval-shaped, white or almost white tablets.
The tablets are presented in triple-layer blisters, containing 2, 4, 8, 12, 14, 24, and 40 tablets, or in aluminum sachets, containing 2, 4, 8, 12, 14, 24, 40, and 100 tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
STADA S.L.
Frederic Mompou 5
08960 Sant Just Desvern
(Barcelona)
Responsible manufacturer
STADA Arzneimittel AG, Stadastr. 2-18, 61118 Bad Vilbel, Germany
or
STADA Arzneimittel Ges.m.b.H,Muthgasse 36/2, 1190 Vienna
or
Lab.Medicamentos Internacionales (Medinsa), La Solana, 26, Torrejon de Ardoz (Madrid) Spain
or
Sanico N.V., Veedijk 59, Industriezone IV, 2300 Turnhout, Belgium
or
Centrafarm Services B.V., Van deReijtstraat31-E, 4814 NE Breda, Netherlands
or
Clonmel Healthcare Ltd., Waterford Road, Clonmel, Co. Tipperary, Ireland
or
Qualiti (Burnley) Limited, talbot Street, Briercliffe, Burnley BB10 2JY, UK
or
Juta Pharma GmbH, Gutenbergstrasse13, 24941 Flensburg, Germany
or
STADA M&D SRL, Str.Trascaului, nr 10, Municipiul Turda, Judet Cluj 401135, Romania
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
GermanyAlendronsäure AL 70 mg Tablets
AustriaAlendronstad 70 mg once weekly - Tablets
BelgiumAlendronat EG 70 mg tablets
DenmarkAlendronate STADA
SpainAlendronic Acid Weekly STADA 70 mg EFG tablets
FranceAlendronate EG 70mg, tablet
NetherlandsAlendroninezuur CF 70 mg, tablets
IrelandOsteomel Once Weekly 70 mg tablets
ItalyAlendronato EG 70 mg compresse
LuxembourgAlendronat EG 70 mg comprimés
MaltaOsteomel Once Weekly 70 mg tablets
PortugalAlendronic Acid Cycle 70mg tablets
SwedenAlendronate STADA Weekly Tablet 70 mg tablets
Last review date of this leaflet:February 2022
The detailed and updated information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.